Drug Topics

OCTOBER 5, 2024

Check out this recap of articles published on our sister sites during the past week.

Vaccines 187

Vaccines 187

STAT

OCTOBER 5, 2024

Rampant consolidation in health care has resulted in higher prices for patients. This consolidation — whether by private equity firms or other large health systems — has not resulted in higher quality care, and in some cases, it has made care quality worse. In September, Ellen MacInnis, a nurse at St. Elizabeth’s Medical Center in Boston, trekked to Washington, D.C., to  testify before a Senate committee  about the extreme cost-savings measures mandated by the hosp

Hospitals 138

Hospitals 138

Drug Topics

OCTOBER 5, 2024

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

76

76

STAT

OCTOBER 5, 2024

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

72

72

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

OCTOBER 5, 2024

Pelabresib, a BET inhibitor, demonstrated meaningful reductions in spleen inflammation and anemia.

66

66

BioPharm

OCTOBER 5, 2024

The best strategy is to use a combination of complementary methods.

59

59